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Abstract
Background: The treatment of eating disorders is a difficult endeavor, with only a relatively small proportion of clients
responding to and completing standard cognitive behavioural therapy (CBT). Given the prevalence of co-morbidity and
complex personality traits in this population, Schema Therapy has been identified as a potentially viable treatment
option. A case series of Group Schema Therapy for Eating Disorders (ST-E-g) yielded positive findings and the
study protocol outlined in this article aims to extend upon these preliminary findings to evaluate group Schema Therapy
for eating disorders in a larger sample (n = 40).
Methods/design: Participants undergo a two-hour assessment where they complete a number of standard
questionnaires and their diagnostic status is ascertained using the Eating Disorder Examination. Participants
then commence treatment, which consists of 25 weekly group sessions lasting for 1.5 h and four individual
sessions. Each group consists of five to eight participants and is facilitated by two therapists, at least one of
who is a registered psychologist trained on schema therapy. The primary outcome in this study is eating disorder symptom
severity. Secondary outcomes include: cognitive schemas, self-objectification, general quality of life, self-compassion, schema
mode presentations, and Personality Disorder features. Participants complete psychological measures and questionnaires at
pre, post, six-month and 1-year follow-up.
Discussion: This study will expand upon preliminary research into the efficacy of group Schema Therapy for individuals with
eating disorders. If group Schema Therapy is shown to reduce eating disorder symptoms, it will hold considerable promise as
an intervention option for a group of disorders that is typically difficult to treat.
Trial registration: ACTRN12615001323516. Registered: 2/12/2015 (retrospectively registered, still recruiting).
Background
The treatment of eating disorders is a difficult endeavor,
with only a relatively small proportion of clients
responding to standard cognitive behavioural therapy
(CBT). Less than half of those with bulimia nervosa
(BN) have recovered at follow-up after receiving CBT
[17, 18, 23] and research supporting cognitive-behavioural
treatment for anorexia nervosa (AN) is limited, with no
clear indication of improvement in this population [6, 8].
Approximately 50% of patients with eating disorders
continue to be highly symptomatic at 60-week follow-up
following transdiagnostic CBT [16]. Further, treatment
dropout rates are high amongst individuals with eating
disorders [9, 43] with one literature review reporting an
average drop-out rate of between 20 and 51% in in-
patient settings and between 29 and 73% in out-
patient settings [20].
The treatment of eating disorders is especially compli-
cated by a high level of co-morbidity [3]. Approximately
69% of individuals with eating disorders may meet DSM
IV (APA, 1994) diagnostic criteria for a personality dis-
order and 93% of these clients may also have other co-
morbidity including anxiety and substance use disorders.
Eating disorders are also associated with the presence of
rigid personality features, which increases clinical
complexity and is associated with poorer treatment out-
comes [22, 26, 46]. Eating disorders have also been
linked to a range of trauma-related risk factors, includ-
ing childhood abuse and neglect, which may also be me-
diated by personality disorder diagnoses [5]. Individuals
with eating disorders also commonly experience com-
plex and difficult-to-treat symptomatology including
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dissociation, perfectionism, compulsive pathology, rigid
thinking patterns [28, 30, 38, 49] and high levels of
shame [7].
Given the prevalence of co-morbidity and complex
personality traits in this population, it is important to
consider the deeper belief systems underlying eating dis-
order presentations. Schema Therapy ([53]/1999) is be-
coming an increasingly popular psychological model for
working with individuals with complex mental health
and personality difficulties. Schema Therapy combines
aspects of cognitive, behavioral, experiential, interper-
sonal and psychoanalytic therapies into one integrative
and unified model [1]. The schemas that are targeted in
treatment are enduring and self-defeating patterns that
typically begin early in life. These patterns consist of
negative/dysfunctional thoughts and feelings which have
been repeated and elaborated upon, and pose obstacles
for accomplishing one’s goals and getting one’s needs
met [40]. These schemas are perpetuated behaviorally
through the coping styles of schema maintenance,
schema avoidance, and schema compensation. The
Schema therapy model of treatment is designed to help
the person break these negative patterns of thinking,
feeling and behaving and develop healthier alternatives
to replace them [1].
The evidence for schema therapy for individuals with
complex mental health difficulties is growing. This ap-
proach has been applied, in both individual and group
forms, to a wide variety of clinical disorders, including,
borderline personality disorder [19, 21] and chronic de-
pression [11, 34, 41, 42]. A recent stringent systematic
review found medium to large effect sizes for schema
therapy in the treatment of a range of psychological con-
ditions [35]. Attention has recently been given to the ap-
plicability of Schema Therapy to individuals with eating
disorders (Pugh, 2015). Evidence suggests that maladap-
tive schemas are more strongly held by individuals with
anorexia and bulimia nervosa compared to normal con-
trols [30]. Preliminary data [33, 38] supports the notion
that it is the schema processes that are engaged in an at-
tempt to avoid intolerable emotional states associated
with these schemas that in fact determine whether an
individual will manifest restrictive or bulimic eating
pathology. Whereas restrictive eating pathology may be
a compulsive behavior developed to prevent schemas be-
ing triggered at all (schema compensation), bulimic
pathology may function alongside other impulsive be-
haviors as a method of escaping schema-related affect
once schemas have already been triggered (schema
avoidance) [33, 38].
Schema therapy has been used in individuals with eating
disorders in one preliminary study [44]. Simpson et al. ex-
amined the use of Group Schema Therapy for Eating
Disorders (STE-g) in a case series of eight participants
with chronic eating disorders and high levels of co-
morbidity. Treatment was comprised of 20 sessions which
included cognitive, experiential, and interpersonal strat-
egies, with an emphasis on behavioral change. Clinically
significant change was observed from pre-treatment to
six-month follow-up for eating disorder severity (d = 1.70),
global schema severity (d = 1.59), shame (d = 0.91), and
anxiety (d = 1.53). Clinically significant change in eating
disorder severity at follow-up was also shown for the ma-
jority of completers (six participants out of eight com-
pleted the full treatment program). Self-report feedback
suggested that group factors may catalyze the change
process in schema therapy by increasing perceptions of
support and encouragement to take risks and try out new
behaviors, whilst providing a de-stigmatizing and de-
shaming therapeutic experience [44].
The present study aims to extend upon the preliminary
findings of Simpson et al. [44] to evaluate Schema Therapy
in a large eating disordered sample (n = 40), in terms of re-
duction of symptoms, and assess feasibility, acceptability
and predictors of outcomes. We aim to conduct 6 groups
of schema therapy in two locations: 1) University of South
Australia in Adelaide Australia and 2) Western Sydney
University in Sydney Australia. The study will examine
whether Schema Therapy reduces eating disorder symp-
toms and improves psychological wellbeing and quality of
life, both at post treatment and follow-up.
Method
Participants
Approximately 40 participants will be recruited into the
study. All participants will be females aged 18 years and
over, meeting Diagnostic and Statistical Manual of Mental
Disorders, 5th Edition criteria for an eating disorder, follow-
ing a transdiagnostic approach (Fairburn, et al., 2003).
Participants are recruited via word of mouth, letters to cli-
nicians and advertisements through Facebook as well as
support organisations such as The Butterfly Foundation.
Participants are provided with information about the study
and, if they agree to participate, are required to give written
consent. Full disclosure of the purpose of the study, the po-
tential benefits and risks associated with participation, and
the confidential nature of information obtained in the study
is explained to participants.
Inclusion/ exclusion criteria
Participants with active psychotic symptoms, high sui-
cide risk or current crisis status (self-disclosed at base-
line), a BMI of less than 14, intellectual disability, and
those who are consuming large amounts of alcohol/
drugs are excluded from the study. All participants must
have a general practitioner involved in their care to
monitor their physical health in order to participate in
this research.
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Overall study design
This study will be an uncontrolled single group repeated
measures design. Ethics approval was secured and
participants provided informed consent to participate.
Participants are first screened over the phone to ensure
suitability for the group. If they agree to participate in
the group, they then undergo a two-hour assessment
where they complete a number of standard question-
naires and their diagnostic status is ascertained. Partici-
pants then commence treatment which consists of 25
weekly group sessions lasting for 1.5 h. Participants are
also provided with four individual sessions that they can
book with one of the therapists whenever they want.
Each group consists of six to eight participants and is
facilitated by two therapists, at least one of whom is a
registered psychologist with training on schema therapy,
and supervised by a schema therapist. Participants
complete psychological measures and questionnaires at
pre, post, 6 month and 1 year follow-up.
Measures
This study utilises a battery of assessments conducted at
baseline, mid-treatment, end-of-treatment, and six- and
twelve-month follow-up points. These assessments are
conducted by fully registered psychologists who have re-
ceived specialized training in the administration of stan-
dardized eating disorder measures. Table 1. Provides a
summary of these assessments.
Eating Disorder Examination (EDE; [15])
The EDE is a structured, investigator-based interview
that measures the severity of symptoms of eating disor-
ders. The scale can be used to ascertain an individual’s
eating disorder diagnosis, as is the purpose of the
measure in the current study. The EDE has been shown
to have excellent reliability when administered by
trained examiners [12].
Eating Disorder Examination- Self-Report Questionnaire Version
(EDE-Q; [14])
The EDE-Q is a 36-item self-report questionnaire for
the assessment and diagnosis of eating disorders. The
EDE-Q yields four subscale scores—Restraint, Eating
Concern, Weight Concern, and Shape Concern—as well
as a global score, which is an average of all four sub-
scales. The EDE-Q has been shown to have good
convergent validity [10, 14]. Acceptable internal
consistency and test–retest reliability have also been
demonstrated [32, 37].
Young Schema Inventory- Short Form (YSQ-SF; [52])
The YSQ-SF is a self-report measure used to assess 15
different maladaptive schemas (emotional deprivation,
abandonment, mistrust/abuse, social alienation, defective-
ness, incompetence, dependency, vulnerability to harm,
enmeshment, subjugation of needs, self-sacrifice, emo-
tional inhibition, unrelenting standards, entitlement, and
insufficient self-control). The scale consists of 75 items
rated from one (completely untrue of me) to six (describes
me perfectly). The scale has been shown to have good psy-
chometric properties [25, 50].
Schema Mode Inventory-Short Form (SMI; [31])
The SMI measures the presence of 14 schemas modes:
Vulnerable Child, Angry Child, Enraged Child, Impulsive
Child, Undisciplined Child, Happy Child, Compliant
Surrender, Detached Protector, Detached Self-Soother,
Self-Aggrandizer, Bully and Attack, Punitive Parent,
Demanding Parent and Healthy Adult modes. The ques-
tionnaire consists of 118 items which are given fre-
quency ratings using a Likert scale ranging from one
(never or hardly ever) to six (always). An overall score is
calculated from the scale sum score divided by the num-
ber of items in that scale. The short form of the SMI has
been shown to have acceptable internal consistencies
amongst the 14 subscales (Cronbach α’s from .79 to .96)
as well as adequate test-retest reliability and moderate
construct validity [31].
World Health Organisation-Five Well-Being Index (WHO-5; [51])
The WHO-5 is an assessment of general wellbeing con-
sisting of five statements (e.g. I have felt cheerful and in
good spirits and I have felt calm and relaxed), which par-
ticipants rate on a six-point scale (from never to always),
with a possible total score varying from 0 to 25. Higher
scores on the WHO-5 reflect better well-being.
Table 1 Assessments conducted at different time points
Measure Baseline Weekly Mid Post 6 months 12 months
EDE x x
EDE-Q x x (abbrev) x x x x
YSQ-SF x x x x x
SMI x x x x x
WHO-5 x x x x x
CORE-10 x x x x x
SCS-SF x x x x x
SATAQ x x x x x
MCMI-III x x
BSL-23 x x x x
Notes: EDE = Eating Disorder Examination; EDE-Q = Eating Disorder Examination-
Questionnaire; YSQ-SF = Young Schema Questionnaire, short form; SMI = Schema
Mode Inventory; WHO-5 =World Health Organisation-Five Well-Being Index;
CORE-10 = Clinical Outcomes in Routine Evaluation-Outcome Measure; SCS =
Self-Compassion Scale- Short Form; SATAQ = Sociocultural Attitudes Towards
Appearance Questionnaire; MCMI-III = Millon Clinical Multiaxial Inventory- III;
BSL-23 = Borderline Symptoms List
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Clinical Outcomes in Routine Evaluation-Outcome Measure
(CORE-10; [2])
The CORE-10 is a self-report measure of general
psychological distress. The CORE-10 includes 10-items
which the respondent rates on a five-point Likert scale
(from not at all to most or all of the time), for example I
have felt tense, anxious or nervous and I have felt panic
or terror. The CORE-10 has been shown to have good
internal reliability (α = .90) and a correlation of.94 with
the CORE-OM [2].
Self-Compassion Scale- Short Form (SCS-SF; [39])
The SCS-SF is a 12-item, self-report scale which assesses
the positive and negative aspects of the three main com-
ponents of self-compassion: Self-Kindness (e.g., When
I’m going through a very hard time, I give myself the car-
ing and tenderness I need) versus Self-Judgment (e.g.,
I’m disapproving and judgmental about my own flaws
and inadequacies); Common Humanity (e.g., When I feel
inadequate in some way, I try to remind myself that feel-
ings of inadequacy are shared by most people) versus Iso-
lation (e.g., When I fail at something that’s important to
me, I tend to feel alone in my failure); and Mindfulness
(When something upsets me I try to keep my emotions in
balance) versus Over-Identification (When I’m feeling
down I tend to obsess and fixate on everything that’s
wrong). Responses are given on a five-point scale ranging
from one (almost never) to five (almost always). A total
self-compassion score is calculated as a mean of all
items and higher scores correspond to higher levels of
self-compassion. The SCS-SF has good psychometric
properties, with high internal consistency (α = .85; [45])
and a very high correlation with the long form of the
SCS [39].
Sociocultural Attitudes Towards Appearance Questionnaire-
Internalization subscale (SATAQ; [24])
The SATAQ is a 14-item inventory assesses women’s
recognition and acceptance of societally prescribed stan-
dards of physical appearance, particularly the thin ideal.
The 8-item Internalization subscale is used in the
present study and measures the extent to which the in-
dividual personally accepts these standards. Statements
such as I tend to compare my body to people in maga-
zines and on TV are rated from one (completely disagree)
to five (completely agree). The SATAQ converges satis-
factorily with other measures of body image and eating
disturbance [24, 47].
Millon Clinical Multiaxial Inventory- III [36]
The MCMI-III is a psychological assessment that pro-
vides information on longstanding personality patterns
and clinical symptomatology. The tool consists of 175
items that are scored on a True/False basis that are
scored to produce 28 clinical subscales. Reliability and
validity studies on the MCMI indicate that is generally a
psychometrically sound instrument. The scale demon-
strates good internal consistency with alpha coeffi-
cients of above.80 for the majority of the scales
(manual). Test-retest reliability has been shown to be
moderate to high [13, 29].
Borderline Symptoms List (BSL-23; [4])
The BSL-23 is a questionnaire used to assess the degree
of symptoms of BPD, such as poor self-esteem,
dysphoric emotions, suicidal intention and impulsive be-
haviors. The scale consists of 23 items (for example: I
experienced stressful inner tension and I wanted to pun-
ish myself ) rated on a five-point Likert scale from 0 (not
at all) to 4 (very strong). A total score is obtained by
summing responses and higher scores represent more
severe BPD symptomatology. The BSL-23 has good
psychometric properties with high internal consistency
(α = 0.94–0.97) and the ability to discriminate personality
disorder patients from patients with other clinical symp-
tomatology (mean effect size of 1.13; [4]).
Primary outcomes
Eating disorder symptom severity is the primary out-
come of this, as measured by the EDE and EDE-Q. The
EDE will be used for pre to post, but due to limited re-
sources only the EDE-Q will be completed at follow-up.
Secondary outcomes
The secondary outcomes measured in this study in-
clude: cognitive schemas (measured using the YSQ);
self-objectification (measured using the SATAQ-
Internalisation); general quality of life (WHO-5 and
CORE-10); self-compassion (SCS-SF); schema mode
presentations (measured using the SMI); and Person-
ality Disorder features (measured using the MCMI-III
and the BSL-23).
Intervention
The schema therapy eating disorder group (STE-g; [44])
was based on the schema mode model, with some
components drawing on the schema-therapy treatment
program: “Schema Focused Therapy in a Group Setting”
[48]. The program consists of twenty-five 90-min
sessions. All participants are provided with a patient-
version workbook which corresponds with the treatment
manual. The first part of the group focuses on schema
psychoeducation and schema-focused cognitive behav-
ioral strategies which help participants to identify and
start challenging their schemas, whilst working on be-
havioral change both within and outside the group. This
model assists participants to develop an individualised
formulation of their own difficulties using a schema
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therapy framework. The highest schemas and modes are
identified for each patient on the basis of their scores on
relevant measures. Each session is recorded and group
members are strongly encouraged to come in to watch
the video should they miss a session. This is to ensure
that participants do not miss any educational material,
and retain a sense of connectedness with the group.
Particular emphasis is placed on linking eating behav-
iors to the schema modes, so that participants are able
to learn about the origins and coping functions associ-
ated with their own pattern of symptoms. Avoidant cop-
ing in the group is addressed frequently by labeling the
“Detached Protector” mode when it is identified either
by group leaders or by other participants (i.e., both in
the context of the group and when talking about eating
behavior which took place between sessions). Use of
over-compensatory behaviors to avoid emotions is also
identified and group members are encouraged to point
this out to each other empathically as the group pro-
gresses. Due to the lack of emotional awareness and
emotional tolerance within the group, participants are
encouraged to learn to express empathy and to ask for
their emotional needs to be met within the context of
the group, rather than detaching from emotional needs
through eating behaviors. Schema-focused mindfulness
meditation [27], is incorporated to increase awareness of
urges to carry out eating disordered behaviors, modes
and associated triggers and to facilitate emotional
regulation.
Participants are helped to identify the origins of their
negative body-image, and to link these to the develop-
ment of particular modes. Body-image restructuring
work involves participants learning to recognise the
way in which their perception and visceral sense of
their bodies differs from the perspective of their most
prominent modes, and developing a compassionate
“Healthy Adult” mode which is accepting and nurturing
toward the body. Mode dialogues are used to enable
group members to repeatedly coach each other to send
the “Critical” mode away when it expresses negative as-
sertions about the body or self (e.g. “You are ugly, fat,
and nobody really likes you”). This gives group partici-
pants the opportunity to practice being in Healthy
Adult mode firstly for others and then for themselves.
Flashcards are used to reinforce what is learned in ses-
sions and to help participants to challenge modes and
resist eating disordered behavior between sessions. In
the four individual sessions the therapist ensure that
the participant understand the schema model, manages
crisis, and engages in schema therapy.
Data analysis
Within-patient standardized effect size information (i.e.,
Cohen’s d) from baseline to end-of-treatment, and from
baseline to follow-up will be calculated for eating psy-
chopathology, and all secondary outcomes. Clinical out-
come data will be analysed using intention to treat
criteria. Data from outcome measures will be analysed
with paired sample T-test. To assess group differences
between the two treatment sites, independent t-tests will
be used. The effect size of outcome measures will be
compared to the effect size reported for previous studies
CBT for eating disorders. The criterion used for statis-
tical significance will be p < 0.05. Sample size was esti-
mated assuming 80% power, significance level at 0.05,
and an effect size of 0.5; 26 people are needed. Assuming
a 50% drop out as documented in previous CBT trials, we
will need around 40 people.
At the completion of the treatment, a random set of
participants will be invited to provide qualitative feed-
back on their experiences of the group treatment. These
interviews will be one-to-one, and conducted either
face-to-face, or via telephone, and are expected to last
for between 30 and 60 min. Transcripts of these inter-
views will be made and the data will be analysed using a
thematic analyses approach. This information will be
used to provide preliminary information about treatment
efficacy and acceptability, and inform the design of
future studies.
Discussion
This study will expand upon preliminary research of
group Schema Therapy for individuals with eating disor-
ders [44]. If group Schema Therapy is shown to reduce
symptoms for this population, it will hold considerable
promise as an intervention option for a group of disor-
ders that is typically difficult to treat.
As this is an uncontrolled study it is limited by not
having a proper comparison to control for confounding
variables. We initially designed this study with a control
group, group Cognitive Behaviour Therapy (CBT), but
then were unable to recruit participants for the CBT
group in Adelaide, and participants only wanted to take
part of the research if they were in the schema therapy
group. This was mostly due to the fact that Adelaide is a
small city and referrals were usually received for severe
cases, as most of the participants so far had completed
CBT before. We do wish to conduct a randomized con-
trolled trial comparing schema therapy to CBT, but that
will need to be conducted in Sydney.
Since the groups are transdiagnostic this has a few ad-
vantages and disadvantages. First, the transdiagnostic ap-
proach for eating disorders is well established, it helps
having different eating disorders as this will provide var-
iety in the group on schemas and modes, which might
facilitate engagement. However, within the group people
might feel very dissimilar to each other within a trans-
diagnostic approach, and the psychologists running the
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groups will keep this in mind to bring unity to the group
by articulating commonalities among participants.
This study will be the first to modify schema ther-
apy to fit the eating disorders sample and to deliver
it to this group. This uncontrolled study will establish
proof of concept and assess feasibility, acceptability
and potential harms. To date, the study has com-
pleted four 25-week group treatments and has com-
menced a further two groups.
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